인쇄하기
취소

CJ to introduce intradermal BCGvaccine SSI in Korea

Published: 2004-02-27 06:58:00
Updated: 2004-02-27 06:58:00
CJ Corporation, a local maker of Capacin inj. (capreomycin) for treatment of tuberculosis infections, saidit has recently entered into an agreement with Denmark-based StatensSerumInstitute (SSI) for the exclusive distribution of BCGvaccine SSI with an aim to improve public health by eradicating tuberculosis.

CJ officials explain that BCGvaccine SSI is used for active immunization against tub...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.